About Us

BroadMed is a complete service pharmaceutical distribution and marketing company licensed to provide regulatory support, market access services, and commercialization solutions. BroadMed is a privately held company with headquarters in Beirut, Lebanon. Our service model includes direct distribution, distribution via partners, marketing and tendering.

WHAT WE DO 

Our business development team continuously seeks new opportunities and partnerships aligned with our portfolio strategy and has the unique capability of executing a comprehensive market evaluation before commercialization. Our methodological research approaches are guided by a product’s scientific integrity, therapeutic impact, and most importantly, safety.

Business Development and Market Analysis

1

Our regulatory affairs department has the experience, expertise and professional relationships with regulatory authorities to ensure accelerated and complete dossier compilation and product variation filing.

Regulatory Affairs and Registration

2

Marketing and Sales Activities

Our team implements marketing strategies tailored to each product guided by our extensive
multinational experience. Promotional effectiveness is optimized by continually developing new marketing strategies and gathering real-time data for sales forecast and management decisions. Our team’s aggressive marketing programs are fundamental for optimizing product penetration.

3

Sales and Distribution

Our GSDP compliant warehouse and distribution infrastruture is centrally located in Sin-el-fil. In Lebanon, we directly cover 85% of pharmacies across the country with a full sales and delivery team. All key institutional buyers are directly covered. BroadMed is registered to tender in all public and private institutions.

4

Medical Affairs

Our team is comprised of internationally trained specialist where their activities range from educating team members, dispersing medical and scientific information to health care providers, and reviewing marketing material for scientific integrity. A centralized pharmacovigilance program is implemented for each product that includes drug safety review and awareness, and adverse event reports.

5

 

© 2018

  • Facebook Social Icon
  • LinkedIn Social Icon